We found that Capn4 siRNA significantly inhibited MMP2 expression in ICC cells, which is in agreement with a previous report that inhibition of Capn4 could reduce MMP2 and MMP9 bioactivities in the diabetic heart [26]. Here, MMP9 is linked to intrahepatic cholangiocarcinoma.